The current stock price of THRM is 37.605 USD. In the past month the price increased by 1.75%. In the past year, price decreased by -2.31%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BWA | BORGWARNER INC | 10.33 | 10.10B | ||
| QS | QUANTUMSCAPE CORP | N/A | 6.77B | ||
| LEA | LEAR CORP | 9.74 | 6.22B | ||
| GNTX | GENTEX CORP | 13.57 | 5.29B | ||
| DORM | DORMAN PRODUCTS INC | 13.79 | 3.75B | ||
| PATK | PATRICK INDUSTRIES INC | 27.04 | 3.64B | ||
| LCII | LCI INDUSTRIES | 16.51 | 3.00B | ||
| DAN | DANA INC | 16.16 | 2.93B | ||
| VC | VISTEON CORP | 8.79 | 2.73B | ||
| PHIN | PHINIA INC | 14.45 | 2.50B | ||
| KDK | KODIAK AI INC | 36.62 | 1.73B | ||
| XPEL | XPEL INC | 29.89 | 1.40B |
Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. The company is headquartered in Novi, Michigan and currently employs 14,246 full-time employees. The firm operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
GENTHERM INC
28875 Cabot Drive
Novi MICHIGAN 48167 US
CEO: PHILLIP EYLER
Employees: 14246
Phone: 12485040500
Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. The company is headquartered in Novi, Michigan and currently employs 14,246 full-time employees. The firm operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
The current stock price of THRM is 37.605 USD. The price decreased by -0.28% in the last trading session.
THRM does not pay a dividend.
THRM has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for GENTHERM INC (THRM) is 18.17. This is based on the reported non-GAAP earnings per share of 2.07 and the current share price of 37.605 USD.
You can find the ownership structure of GENTHERM INC (THRM) on the Ownership tab.
ChartMill assigns a technical rating of 6 / 10 to THRM. When comparing the yearly performance of all stocks, THRM turns out to be only a medium performer in the overall market: it outperformed 53.2% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to THRM. THRM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months THRM reported a non-GAAP Earnings per Share(EPS) of 2.07. The EPS decreased by -29.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.06% | ||
| ROA | 2.19% | ||
| ROE | 4.22% | ||
| Debt/Equity | 0.26 |
12 analysts have analysed THRM and the average price target is 46.51 USD. This implies a price increase of 23.69% is expected in the next year compared to the current price of 37.605.
For the next year, analysts expect an EPS growth of 5.3% and a revenue growth 1% for THRM